申请人:Merck Sharp & Dohme Corp.
公开号:US20150175575A1
公开(公告)日:2015-06-25
The present invention provides novel imidazole analogs of Formula I which are potent inhibitors of spleen tyrosine kinase, and are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD, rheumatoid arthritis, and cancer.
本发明提供了一种新型
咪唑类似物I的化合物,它们是脾
酪氨酸激酶的有效
抑制剂,可用于治疗和预防由该酶介导的疾病,如哮喘、
COPD、类风湿性关节炎和癌症。